Clinicians should engage patients in transparent cost discussions before prescribing, verify insurance coverage and prior authorization requirements, and provide information about manufacturer assistance programs
If you want the clinical review: If you want the clinical review: If you want the clinical review: 26 Tremellen, Kelton
No supplement, including resM, has demonstrated weight loss results anywhere near the 15-20% body weight reductions achieved by tirzepatide and semaglutide in large randomized trials
This widespread receptor distribution explains why the effects go beyond simple appetite suppression or glucose management
The shortage has ended, so compounding these drugs without a valid medical need now violates federal law
AJMC , Trump Announces Deals With Lilly, Novo for Lower Weight Loss Drug Prices (Nov 2025) ( [22] )